UCL has made dementia a priority
Dementia is the greatest scientific, medical and socio-economic challenge of our times and affects more than 46 million people worldwide. As populations age, dementia is inevitably going to become more common with devastating personal, social and economic implications.
UCL can lay claim to world-leading expertise across the spectrum of research, from genetics to evidence based treatments and support for patients and carers. We have both the ambition and ability to make a difference and meet the challenge of this most pressing of global public health problems.
The UK Dementia Research Institute is a joint investment into dementia research led by the Medical Research Council alongside founding charity partners Alzheimer’s Society and Alzheimer’s Research UK. The Institute will be catalytic in the UK’s research efforts to diagnose, treat, care for and prevent dementias, a group of neurodegenerative disorders which include Alzheimer’s, Parkinson’s, Huntington’s disease and vascular dementia. The hub of the institute activity and operational headquarters is based at UCL.
UCL has again made the top ten in the latest rankings of UK universities by The Times and The Sunday Times which also includes new figures showing that UCL’s graduates are among the highest paid six months after leaving.
Published: Sep 22, 2017 11:17:20 AM
Alzheimer’s Research UK will invest over £2 million in four innovative new projects exploring ways to reduce the risk of dementia, one of which is led by UCL researchers.
Published: Sep 21, 2017 10:16:43 AM